Business Description
Founded in 2006 and based in Beijing, Immunotech Biopharm Ltd is a Chinese biopharmaceutical company dedicated to developing treatments that use the body's own immune cells to fight cancer. Its most advanced product, EAL, is currently in Phase III trials aimed at stopping liver cancer from returning after surgery, while several other treatments targeting blood cancers, ovarian cancer, and solid tumors are at earlier stages of testing. The company is also working on a pipeline of pre-clinical therapies designed to address both malignant blood disorders and infections that can arise following organ transplants.
